Selenite changes key properties of pancreatic cancer cells in experimental models
Researchers at Karolinska Institutet report in the Journal of Experimental & Clinical Cancer Research that sodium selenite not only can damage tumor cells but also influence characteristics linked to tumor aggressiveness and treatment response. The findings are based on both cell experiments and analyses of tumor tissue from patients with pancreatic cancer.
Researchers from Karolinska Institutet suggest in their recent study published in the Journal of Experimental & Clinical Cancer Research that sodium selenite, a form of selenium, not only damages pancreatic cancer cells but also alters their characteristics. The study, which involved laboratory models and patient tissue samples, demonstrates that the effects of selenite depend on the dose and type of tumor tissue.
In certain cancer cells, exposure to high doses of selenite resulted in less aggressive characteristics, as evidenced by reduced tumor cell damage and the development of less aggressive features, particularly in specific regions of the tumor tissue. However, it is important to note that the study was conducted in experimental models and does not establish any clinical treatment effects in patients.
Additionally, the number of patient samples was limited, which restricted the extent of some analyses. The research was a collaborative effort involving research and clinical pathology groups at Karolinska Institutet and Karolinska University Hospital.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — it may contain errors, so check the original before relying on it.
